Tweenvest Stocks

Rhythm Biosciences Limited (ASX: RHY)

Health Care · Health Care Providers & Services · AU

AU$0.08

-6.25% today · -22.7% 1Y

Rhythm Biosciences Limited (ASX: RHY) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $18.52M and employs 23 people.

Over the last twelve months the share price has lost 22.7%, trading between 0.07 and 0.28.

Tweenvest scores Rhythm Biosciences Limited across four factors: quality 35/100, value 46/100. Its strongest factor is value.

RHY price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$18.52M
Revenue (TTM)
$1.20M
P/E
—
EPS
-0.02
Dividend yield
—
Beta (5Y)
0.57
52-week high
AU$0.28
52-week low
AU$0.07
Avg volume (3M)
—
Shares outstanding
353.87M
Employees
23
Next earnings
—

About Rhythm Biosciences Limited

Rhythm Biosciences Limited functions as a forward-thinking enterprise focused on predictive cancer diagnostics, active across both Australian and global territories. The company's core operations involve the creation, advancement, and market introduction of cutting-edge medical diagnostic technologies. A key innovation is ColoSTAT, their specialized blood test designed for the prompt and reliable identification of colorectal cancer. Established in 2017, the firm's main offices are located in Parkville, Australia.

ISIN
AU000000RHY2
Founded
2017
Listed since
Dec 6, 2017
Exchange
Australian Securities Exchange
Currency
AUD
CompanyMarket capPriceDay
FB Care Service Co.,Ltd.TSE: 9220$19.61M¥1,274.00-2.38%
P3 Health Partners Inc.NasdaqCM: PIII$19.36M$4.61-6.87%
Vaidya Sane Ayurved Laboratories LimitedNSEI: MADHAVBAUG$19.24MRs177.00-0.31%
MRT Inc.TSE: 6034$18.80M¥544.00-5.06%
AsiaMedic LimitedCatalist: 505$18.20MS$0.02+17.65%
GLOME Holdings,Inc.TSE: 8938$18.18M¥318.00-3.05%
VijayPD Ceutical LimitedNSEI: VIJAYPD$17.85MRs88.45+10.49%
BTB Korea Co.,LtdKOSDAQ: A219750$17.63M₩1,812.00+5.66%

Browse every Health Care Providers & Services company →

Figures last refreshed Oct 11, 2026.